Clevergene
PrivateLast Round
Seed
Feb 12, 2020
Total Funding Raised
$631,000
Company Overview
Clevergene is a biotechnology company that provides integrated genomics services, including next-generation sequencing, bioinformatics, and genetic diagnostics for research and clinical applications.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Drug Discovery, Healthcare Analytics
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Clevergene Comparables
Compare Clevergene with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| SciGenom Labs | 86% | |
| Nucleome Informatics Private Limited | 86% | |
| Genotypic Technology | 83% | |
Clevergene Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Feb 12, 2020 |
Clevergene Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Auxano Capital | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 8, 2025
Grew 19% QoQ, from 16 to 19 employees.
- May 9, 2025
Grew 27% QoQ from 15 to 19 employees.
Clevergene Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Clevergene's valuation, stock price, and market status.